Philadelphia Invokana Kidney Lawsuits – Current Invokana Lawsuit Information for Residents of Philadelphia
Persons and the families of persons in Philadelphia who have suffered severe injuries or wrongful death while taking Invokana may be entitled to real compensation through filing a Philadelphia Invokana injury lawsuit. Patients in Philadelphia were not warned of the serious side effects posed by the drug, which include kidney failure and other kidney problems, ketoacidosis or blood acid problems, and cardiovascular problems such as heart attack and stroke. Given that there are alternative drugs which were widely prescribed to Type II diabetics prior to the release of this drug, it is reasonable to think many Philadelphia patients would have chosen an alternative had they known about the potential for serious Invokana side effects.
Today, physicians and researchers question whether there are true benefits from Invokana that could ever outweigh its many risks.
Experts assert that Janssen knew of or suspected the risks posed by Invokana before the drug was approved in 2013. Invokana lawsuits allege that Janssen failed to adequately research the risks posed by the drug or to warn consumers.
Given that approximately 26 million Americans suffer from Type II diabetes, and that Invokana quickly rose to popularity due to aggressive marketing campaigns, it is reasonable to think that many Americans, including residents of Philadelphia, have suffered from side effects or wrongful death and have grounds to file Philadelphia Invokana lawsuits. Attorneys believe that as this information reaches the public, Janssen will face an onslaught of Invokana lawsuits, which are likely to be consolidated as a multidistrict litigation in U.S. District Court.
Experts say Janssen knew of Invokana’s risks but failed to warn consumers.
Janssen has faced numerous product liability lawsuits in recent years, including litigation for injuries and wrongful death related to Topamax, Risperdal, Xarelto, Invega, and Natracor. Janssen and its parent corporation Johnson & Johnson resolved a federal lawsuit filed by the U.S. Department of Justice in 2013 by agreeing to pay $1.391 billion. The company was accused of marketing Risperdal, Invega and Natracor for off-market purposes. Xarelto is currently the subject of a multidistrict litigation in U.S. District Court in the Eastern District of Louisiana; the litigation has swelled to include more than 550 national cases as of June 2015.
Philadelphia Invokana lawsuits can be filed by persons and the family members of persons in Philadelphia who suffered from severe health problems while taking the drug. Philadelphia Invokana lawsuits allege that Janssen Pharmaceuticals had a responsibility to warn consumers of the potential for kidney problems, cardiovascular problems, and ketoacidosis, and wrongful death stemming from the drug.
Invokana Lawsuits in Philadelphia
If you or a family member suffered from serious health problems such as ketoacidosis, blood acid problems, kidney failure, kidney impairment, stroke, or heart attack while taking Invokana in Philadelphia you may have legal grounds to file a Philadelphia Invokana injury lawsuit. Filing a lawsuit is the only way to secure compensation for medical bills, lost time at work, pain, suffering and loss that have resulted from Invokana side effects. Our lawyers handle Invokana wrongful death lawsuits in Philadelphia and throughout the United States, and offer no-cost, no-obligation Invokana injury case review for persons in Philadelphia who match this description. To discuss your situation in detail with an attorney and to learn about Invokana kidney lawsuit time limits inPhiladelphia, please complete our online contact form. One of our attorneys handling Philadelphia Invokana ketoacidosis lawsuits will contact you promptly.
Philadelphia Invokana Lawsuits Are Not Class Action Lawsuits
Many Philadelphia persons affected by Invokana side effects such as heart attack, kidney problems, stroke, or ketoacidosis wonder if filing an Invokana lawsuit will bring about meaningful compensation for their family. Philadelphia Invokana injury lawsuits are not class action lawsuits, in which each plaintiff can expect to receive only a small settlement. Invokana kidney and ketoacidosis lawsuits from Philadelphia will likely join forces with more actions nationwide into a Multi-District Litigation (MDL), in which each case will be handled on its own merit and each plaintiff can expect compensation that is determined by their particular circumstance and degree of suffering.
Our firm represents all persons involved in an Invokana lawsuit in Philadelphia on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. For a free no-obligation consultation, complete our brief online contact form. One of our Philadelphia Invokana lawyers will contact you shortly to answer your questions as definitively as possible.
No-Cost, No-Obligation Philadelphia Invokana Lawsuit Case Review for Persons or Families of Persons in Philadelphia Who Suffered from Kidney Failure, Ketoacidosis, Cardiovascular Problems, or Wrongful Death
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others, and other law firms throughout the nation often seek its experience and expertise on complex litigation. For more information, visit www.OnderLaw.com or call 1-877-ONDER-LAW.